Cargando…

Stentless aortic valves. Current aspects

The design of stentless valve prostheses is intended to achieve a more physiological flow pattern and superior hemodynamics in comparison to stented valves. First - generation stentless bioprosthesis were the Prima valve, the Freestyle valve and the Toronto stentless porcine valve. The second genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ennker, J, Albert, A, Ennker, I C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484938/
https://www.ncbi.nlm.nih.gov/pubmed/23439732
_version_ 1782248210984599552
author Ennker, J
Albert, A
Ennker, I C
author_facet Ennker, J
Albert, A
Ennker, I C
author_sort Ennker, J
collection PubMed
description The design of stentless valve prostheses is intended to achieve a more physiological flow pattern and superior hemodynamics in comparison to stented valves. First - generation stentless bioprosthesis were the Prima valve, the Freestyle valve and the Toronto stentless porcine valve. The second generation of stentless valves, as the Super stentless aortic porcine valve, need only one suture line. The Sorin Pericarbon Freedom and the Equine 3F heart Valve belong to the third generation of stentless valve pericardial bioprostheses. A stentless valve to replace a full root can be implanted by several surgical techniques: complete or modified subcoronary, root inclusion and full root. The full root technique is accompanied by the lowest incidence of patient-prothesis mismatch. Our own clinical experience reflects more than 3000 stentless valve implantations since April 1996. Randomized study trials showed a hemodynamic advantage for stentless valves, but several could not reach a significant level. Also reported was a significant advantage of stentless bioprostheses concerning transvalvular gradients, effective valve area and quicker regression of the left ventricular mass 6 months after the operation, but at 12 months. Advantages are obvious in patients with a decreased left ventricle ejection fraction of less than 50% and in smaller implanted valve size, concomitant aortic root pathology (e.g. dissection) and aortic valve endocarditis. A survival advantage for stentless bioprostheses in comparison to stented ones has been reported by all studies in the literature. Stentless valves enrich the surgical armamentarium. Time will define the place of stentless valves in the future.
format Online
Article
Text
id pubmed-3484938
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher EDIMES Edizioni Internazionali Srl
record_format MEDLINE/PubMed
spelling pubmed-34849382013-02-25 Stentless aortic valves. Current aspects Ennker, J Albert, A Ennker, I C HSR Proc Intensive Care Cardiovasc Anesth Brief-Report The design of stentless valve prostheses is intended to achieve a more physiological flow pattern and superior hemodynamics in comparison to stented valves. First - generation stentless bioprosthesis were the Prima valve, the Freestyle valve and the Toronto stentless porcine valve. The second generation of stentless valves, as the Super stentless aortic porcine valve, need only one suture line. The Sorin Pericarbon Freedom and the Equine 3F heart Valve belong to the third generation of stentless valve pericardial bioprostheses. A stentless valve to replace a full root can be implanted by several surgical techniques: complete or modified subcoronary, root inclusion and full root. The full root technique is accompanied by the lowest incidence of patient-prothesis mismatch. Our own clinical experience reflects more than 3000 stentless valve implantations since April 1996. Randomized study trials showed a hemodynamic advantage for stentless valves, but several could not reach a significant level. Also reported was a significant advantage of stentless bioprostheses concerning transvalvular gradients, effective valve area and quicker regression of the left ventricular mass 6 months after the operation, but at 12 months. Advantages are obvious in patients with a decreased left ventricle ejection fraction of less than 50% and in smaller implanted valve size, concomitant aortic root pathology (e.g. dissection) and aortic valve endocarditis. A survival advantage for stentless bioprostheses in comparison to stented ones has been reported by all studies in the literature. Stentless valves enrich the surgical armamentarium. Time will define the place of stentless valves in the future. EDIMES Edizioni Internazionali Srl 2012 /pmc/articles/PMC3484938/ /pubmed/23439732 Text en Copyright © 2012, HSR Proceedings in Intensive Care and Cardiovascular Anesthesia http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License 3.0, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode.
spellingShingle Brief-Report
Ennker, J
Albert, A
Ennker, I C
Stentless aortic valves. Current aspects
title Stentless aortic valves. Current aspects
title_full Stentless aortic valves. Current aspects
title_fullStr Stentless aortic valves. Current aspects
title_full_unstemmed Stentless aortic valves. Current aspects
title_short Stentless aortic valves. Current aspects
title_sort stentless aortic valves. current aspects
topic Brief-Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484938/
https://www.ncbi.nlm.nih.gov/pubmed/23439732
work_keys_str_mv AT ennkerj stentlessaorticvalvescurrentaspects
AT alberta stentlessaorticvalvescurrentaspects
AT ennkeric stentlessaorticvalvescurrentaspects